SARS-CoV-2 Associated Respiratory Failure in a Preterm Infant and the Outcome after Remdesivir Treatment
Mohammed A. Sarhan, Maria Casalino, Pongsatorn Paopongsawan, David Gryn, Tapas Kulkarni, Ari Bitnun, Estelle B. Gauda
Abstract
Severe coronavirus disease 2019 (COVID-19) occurs in approximately 10% of neonates infected with severe acute respiratory syndrome coronavirus 2. Guidelines for optimal management of severe COVID-19 in neonates do not exist. In this report, we describe a late-preterm neonate with severe COVID-19, requiring invasive mechanical ventilation who recovered following treatment with remdesivir and high dose dexamethasone.
Topics & Concepts
MedicineRespiratory failureMechanical ventilationIntensive care medicineCoronavirusOutcome (game theory)Respiratory systemPediatricsRespiratory diseaseAcute respiratory failureSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Coronavirus disease 2019 (COVID-19)DiseaseArtificial ventilationPneumonia2019-20 coronavirus outbreakEmergency medicineVentilation (architecture)BetacoronavirusPopulationSeverity of illnessNoninvasive ventilationCOVID-19 Impact on ReproductionCOVID-19 Clinical Research StudiesNeonatal Respiratory Health Research